DM
BLTE

Deerfield Management’s Belite Bio BLTE Stock Holding History

Deerfield Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55M Buy
357,199
+53,186
+17% +$8.15M 0.57% 47
2026
Q1 		$48.5M Buy
304,013
+70,200
+30% +$11.8M 0.57% 46
2025
Q4 		$37.4M Buy
+233,813
New +$27.7M 0.48% 45

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Deerfield Management's BLTE Position: Q2 2026 in Review

Deerfield Management increased its Belite Bio (BLTE) stake by 17% in Q2 2026, buying an estimated $8.15M and bringing the position to 357,199 shares worth $55M. The position accounts for 0.57% of the portfolio, ranked #47.

Deerfield Management first reported a position in BLTE in Q4 2025 and has held it in 3 quarters since. 81 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Deerfield Management held 357,199 shares of Belite Bio worth $55M as of Q2 2026.
  • Deerfield Management bought 53,186 Belite Bio shares in Q2 2026, an estimated $8.15M.
  • Belite Bio made up 0.57% of Deerfield Management's portfolio in Q2 2026, its #47 holding.
  • Deerfield Management first reported a position in Belite Bio in Q4 2025 and has held it in 3 quarters since.
  • 81 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.